JAK1 and JAK2 activation in healthy versus inflamed gums
Official title: Unraveling the Role of JAK1 and JAK2 Pathway in Periodontitis: Drivers of Immunopathology and Possible Therapeutic Targets
Run by University of Chile · NCT07536204 · Data updated 2026-11-12
We will test whether the JAK1 and JAK2 immune-signaling pathways are more active in adults with periodontitis than in adults with healthy gums.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Chile Academic / other |
| Drugs / interventions | Chemotherapy, radiation |
| Locations | 1 site (Santiago, Metropolitan Region) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | March 31, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT07536204 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who are systemically healthy and able to undergo a single gingival biopsy visit, including those with clinically healthy gingiva or with periodontitis, who are not pregnant and do not have recent immunosuppressive or antibiotic exposure, are ideal candidates.
✕Probably not a fit
People with active malignancy, recent chemotherapy or head/neck radiation, chronic viral infections (HBV/HCV/HIV), autoimmune disease, diabetes, recent immunosuppressive or cytokine therapy, heavy smoking (>10 cigarettes/day), pregnancy or lactation are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects gingival biopsy samples from adults with healthy gums and from adults with periodontitis at a single clinic visit. Tissue samples will be analyzed for JAK1 and JAK2 pathway activation and mapped to histological compartments such as epithelium and lamina propria and to specific cell subpopulations. All participants will receive diagnosis and standard dental treatment for their gingival condition. No experimental drug or device is administered.
Why it matters
Potential benefit: If successful, the findings could point to JAK1/2 as a target for new treatments that reduce gum inflammation and attachment loss.
How similar studies have gone: JAK pathway activation and JAK inhibitor benefit have been demonstrated in other inflammatory diseases, but applying detailed gingival biopsy profiling to link JAK1/2 specifically to periodontitis is a relatively novel, mechanistic approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults * Sistemically healthy Exclusion Criteria: * Active Maliganancy * History of radiation to the head-neck region * Chemotherapy or radiation within the last 5 years * History of hepatitis B/C or HIV infection * Autoimmune diseases * Diagnosis of diabetes * Pregnancy or lactation * More than 3 hospitalizations over the last 3 years * Use of systemic antibiotics over the last 3 months * Use of systemic corticosteroids or immunosuppressants over the last 3 months * Use of cytokine therapy over the last 3 months * Use of large doses of pre/probiotic supplements over the last 3 months * Smoke more than 10 cigarettes per day
Where it's running
-
Faculty of Dentistry, University of Chile
Santiago, Metropolitan Region, Chile Recruiting
Study contacts
- Study coordinator: Nicolas Dutzan, DDS, PhD
- Email: ndutzan@uchile.cl
- Phone: +56934037995
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Platelet-rich fibrin added to deep tooth cleaning for periodontitis
This will try adding platelet-rich fibrin (PRF) to deep non-surgical cleaning to see if it improves gum healing and attachment in adults with stage II–IV periodontitis.
-
Hyaluronic acid and octenidine gel with non-surgical gum treatment
This pilot will test whether adding a hyaluronic acid and octenidine gel to non-surgical periodontal treatment helps adults with advanced periodontitis heal faster and reduce inflammation.
-
Treatment of gum defects using hyaluronic acid and polynucleotides
This study is testing if adding a special gel to gum surgery helps people with gum disease heal better and faster.
-
See if periodontal treatment improves chewing ability and oral quality of life
This study tests whether treating periodontitis improves how well people can chew and how they feel about their oral health.
-
Candida albicans and periodontitis in Syrian patients
This project will test whether Candida albicans is commonly present in the gum pockets of Syrian adults with chronic periodontitis.
-
Online self-check to identify your gum disease risk and guide preventive care
This project will test whether an online questionnaire can accurately identify gum disease risk in adults with natural teeth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.